Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,977 public trials 2,028 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Prospective Cohort Study With Central Nervous System Evaluation in Diffuse Large B-cell Lymphoma

NCT01202448

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Samsung Medical Center Seoul, South Korea

Asan Medical Center Seoul, South Korea

View Trial Details

Completed

Engraftment Syndrome After Autologous Stem Cell Transplant: Retrospective Review in Patients With Multiple Myeloma

NCT01622582

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

View Trial Details

Completed

Effect of Omega-3 Fatty Acids on Methotrexate Induced Hepatotoxicity in Children With Acute Lymphoblastic Leukemia

NCT02373579

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Not specified

View Trial Details

Completed

A Pilot Study to Determine the Safety of the Combination of Ontak in Combination With CHOP in Peripheral T-Cell Lymphoma

NCT00337987

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Yale Comprehensive Cancer Center at Yale University School of Medicine New Haven, Connecticut, United States

View Trial Details

Completed

Panobinostat (LBH589) Plus Everolimus (RAD001) in Patients With Relapsed and Refractory Lymphoma

NCT00967044

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +11 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

SGN-30 and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma

NCT00337194

Conditions: Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin Lymphoma, +11 more
Locations: Cancer and Leukemia Group B Chicago, Illinois, United States

View Trial Details

Completed

Bortezomib, Dexamethasone, and Rituximab in Untreated Waldenstroms Macroglobulinemia

NCT00832234

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: University of Athens School of Medicine Athens, Greece

View Trial Details

Completed

Intrathecal Rituximab in Treating Patients With Recurrent CNS Lymphoma

NCT00416923

Conditions: Blood Protein Disorders, Brain and Central Nervous System Tumors, Burkitt Lymphoma, +46 more
Locations: Not specified

View Trial Details

Completed

A Safety Study of Rituximab Plus MTX Injected Into the Cerebrospinal Fluid in the Treatment of Brain Lymphoma

NCT00221325

Conditions: Central Nervous System Lymphoma, Eye Neoplasms, Hemic and Lymphatic Diseases, +9 more
Locations: University of California, San Francisco San Francisco, California, United States

Massachusetts General Hospital Boston, Massachusetts, United States

Memorial Sloan-Kettering Cancer Center New York, United States

MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY

NCT00809276

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +34 more
Locations: The Sydney Kimmel Comprehensive Cancer center Baltimore, Maryland, United States

Marcos deLima, MD Houston, Texas, United States

Paul V. O'Donnell, M.D., Ph.D. Seattle, Washington, United States

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions